| IFNGR2 |
P38484
|
interferon gamma receptor 2
|
Receptor
|
0.95 |
0.597 |
0.577 |
| UBE2B |
P63146
|
ubiquitin conjugating enzyme E2 B
|
|
0.20 |
0.644 |
0.615 |
| MIR224 |
|
microRNA 224
|
|
|
0.534 |
0.654 |
| IFNGR1 |
P15260
|
interferon gamma receptor 1
|
Receptor
|
1.6E-02 |
0.529 |
0.692 |
| PNPLA3 |
Q9NST1
|
patatin like phospholipase domain containing 3
|
Enzyme
|
5.7E-08 |
0.556 |
0.692 |
| CD247 |
P20963
|
CD247 molecule
|
|
1.7E-02 |
0.539 |
0.731 |
| GEM |
P55040
|
GTP binding protein overexpressed in skeletal muscle
|
|
1.2E-08 |
0.467 |
0.769 |
| HLA-E |
P13747
|
major histocompatibility complex, class I, E
|
|
3.7E-02 |
0.545 |
0.769 |
| IL1R1 |
P14778
|
interleukin 1 receptor type 1
|
Receptor
|
0.15 |
0.509 |
0.769 |
| IL15RA |
Q13261
|
interleukin 15 receptor subunit alpha
|
|
2.3E-06 |
0.603 |
0.769 |
| IRF1 |
P10914
|
interferon regulatory factor 1
|
Transcription factor
|
0.99 |
0.468 |
0.769 |
| HBB |
P68871
|
hemoglobin subunit beta
|
|
1.2E-09 |
0.494 |
0.808 |
| CXCL9 |
Q07325
|
C-X-C motif chemokine ligand 9
|
Signaling
|
2.9E-03 |
0.462 |
0.808 |
| TRAF6 |
Q9Y4K3
|
TNF receptor associated factor 6
|
Signaling
|
1.00 |
0.472 |
0.808 |
| HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
| HAVCR2 |
Q8TDQ0
|
hepatitis A virus cellular receptor 2
|
|
3.9E-02 |
0.450 |
0.808 |
| UCA1 |
|
urothelial cancer associated 1
|
|
|
0.512 |
0.808 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| HLA-C |
P10321
|
major histocompatibility complex, class I, C
|
|
1.6E-06 |
0.415 |
0.846 |
| IL15 |
P40933
|
interleukin 15
|
|
0.71 |
0.422 |
0.846 |
| LEP |
P41159
|
leptin
|
|
0.46 |
0.349 |
0.846 |
| MDM2 |
Q00987
|
MDM2 proto-oncogene
|
Nucleic acid binding
|
1.00 |
0.362 |
0.846 |
| POMC |
P01189
|
proopiomelanocortin
|
|
1.2E-04 |
0.356 |
0.846 |
| CCL18 |
P55774
|
C-C motif chemokine ligand 18
|
Signaling
|
9.2E-03 |
0.489 |
0.846 |
| TBC1D9 |
Q6ZT07
|
TBC1 domain family member 9
|
Enzyme
|
2.8E-05 |
0.399 |
0.846 |